Rapid development of the FDA ACMT COVID-19 ToxIC (FACT) pharmacovigilance pilot project to monitor adverse events reported in association with COVID-19 therapeutics

Aldy, K.; Wax, P.; Brent, J.; Marshall, S.; Campleman, S.; Abston, S.; Meyn, A.; Diak, I. L.; Konkel, K.; Mundkur, M.; Dang, O.; Burkhart, K.; Tox, I. C. Fact Study Grp

Aldy, K.; Wax, P.; Brent, J.; Marshall, S.; Campleman, S.; Abston, S.; Meyn, A.; Diak, I. L.; Konkel, K.; Mundkur, M.; Dang, O.; Burkhart, K.; Tox, I. C. Fact Study Grp.

Clinical Toxicology ; 59(11):1054-1054, 2021.

文章在英语 | Web of Science | ID: covidwho-1489302

Search on Google

打印

XML

采集: 国际组织的数据库 资料库: Web of Science 语言: 英语 期刊: Clinical Toxicology 年: 2021 类型: 文章

相关文档